| MiRNA | Compound | Condition | Effect | Throughput | PMID | Details |
|---|---|---|---|---|---|---|
| miR-101 | ABT-263 (navitoclax) | colorectal cancer | Sensitive | High | 20829195 | |
| miR-105 | ABT-263 (navitoclax) | colorectal cancer | Sensitive | High | 20829195 | |
| miR-1233 | ABT-263 (navitoclax) | colorectal cancer | Sensitive | High | 20829195 | |
| miR-148b* | ABT-263 (navitoclax) | colorectal cancer | Sensitive | High | 20829195 | |
| miR-153 | ABT-263 (navitoclax) | colorectal cancer | Sensitive | High | 20829195 | |
| miR-193a | ABT-263 (navitoclax) | colorectal cancer | Sensitive | High | 20829195 | |
| miR-218-1* | ABT-263 (navitoclax) | colorectal cancer | Sensitive | High | 20829195 | |
| miR-29b-1 | ABT-263 (navitoclax) | colorectal cancer | Sensitive | High | 20829195 | |
| miR-29b-2* | ABT-263 (navitoclax) | colorectal cancer | Sensitive | High | 20829195 | |
| miR-380 | ABT-263 (navitoclax) | colorectal cancer | Sensitive | High | 20829195 | |
| miR-518a | ABT-263 (navitoclax) | colorectal cancer | Sensitive | High | 20829195 | |
| miR-582 | ABT-263 (navitoclax) | colorectal cancer | Sensitive | High | 20829195 | |
| miR-605 | ABT-263 (navitoclax) | colorectal cancer | Sensitive | High | 20829195 | |
| miR-661 | ABT-263 (navitoclax) | colorectal cancer | Sensitive | High | 20829195 | |
| miR-744* | ABT-263 (navitoclax) | colorectal cancer | Sensitive | High | 20829195 | |
| miR-876 | ABT-263 (navitoclax) | colorectal cancer | Sensitive | High | 20829195 | |
| miR-886 | ABT-263 (navitoclax) | colorectal cancer | Sensitive | High | 20829195 | |
| miR-892b | ABT-263 (navitoclax) | colorectal cancer | Sensitive | High | 20829195 | |
| miR-935 | ABT-263 (navitoclax) | colorectal cancer | Sensitive | High | 20829195 |